From: Effects of variations in access to care for children with atopic dermatitis
 | Dermatologist | A/I | Pediatrics | Other |
---|---|---|---|---|
Number of patients, n (%) | 58,758 (12.3) | 29,994 (6.3) | 169,455 (35.5) | 219,277 (45.8) |
Systemic antihistamine use, n (%) | 17,195 (29.3) | 13,146 (43.8) | 63,904 (37.7) | 128,083 (58.4) |
 Non-sedating antihistamine onlya, n (%) | 4651 (27.0) | 6556 (49.9) | 32,424 (50.7) | 63,284 (49.4) |
  ≥1 sedating antihistamine, n (%) | 12,544 (72.9) | 6590 (50.1) | 31,480 (49.3) | 64,799 (50.6) |
Medicaid-insured patients, n (%) | 8160 | 7144 | 60,268 | 165,076 |
Systemic antihistamine use, n (%) | 5933 (72.7) | 6123 (85.7) | 42,416 (70.4) | 116,039 (70.3) |
 Non-sedating antihistamine onlya, n (%) | 2467 (41.6) | 3897 (63.6) | 25,852 (60.9) | 59,976 (51.7) |
  ≥1 sedating antihistamine, n (%) | 3466 (58.4) | 2226 (36.4) | 16,564 (39,1) | 56,063 (48.3) |
Commercially insured patients, n (%) | 50,598 | 22,850 | 109,187 | 54,201 |
Systemic antihistamine use, n (%) | 11,262 (22.3) | 7023 (30.7) | 21,488 (19.7) | 12,044 (22.2) |
 Non-sedating antihistamine onlya, n (%) | 2184 (19.4) | 2659 (37.9) | 6572 (30.6) | 3308 (27.5) |
  ≥1 sedating antihistamine, n (%) | 9078 (80.6) | 4364 (62.1) | 14,916 (69.4) | 8736 (72.5) |